Spruce Biosciences Announces Board and Compensation Changes
Ticker: SPRB · Form: 8-K · Filed: Oct 17, 2025 · CIK: 1683553
| Field | Detail |
|---|---|
| Company | Spruce Biosciences, Inc. (SPRB) |
| Form Type | 8-K |
| Filed Date | Oct 17, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
Related Tickers: SPRB
TL;DR
Spruce Bio board shakeup & comp changes filed 10/15.
AI Summary
Spruce Biosciences, Inc. announced on October 15, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory plans for key personnel.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate internal shifts that may affect future performance and strategic direction.
Key Players & Entities
- Spruce Biosciences, Inc. (company) — Registrant
- October 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080 (address) — Principal Executive Offices
- 415-655-4168 (phone_number) — Registrant's Telephone Number
FAQ
What specific items are being reported under the 8-K filing?
The filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
When was the earliest event reported in this filing?
The earliest event reported was on October 15, 2025.
What is Spruce Biosciences, Inc.'s state of incorporation?
Spruce Biosciences, Inc. is incorporated in Delaware.
Where are Spruce Biosciences, Inc.'s principal executive offices located?
The principal executive offices are located at 611 Gateway Boulevard, Suite 740, South San Francisco, California 94080.
What is the company's SIC code?
The Standard Industrial Classification code for Spruce Biosciences, Inc. is 2834, Pharmaceutical Preparations.
Filing Stats: 434 words · 2 min read · ~1 pages · Grade level 12.5 · Accepted 2025-10-17 16:05:26
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SPRB Nasdaq Capital Marke
Filing Documents
- sprb-20251015.htm (8-K) — 51KB
- 0001193125-25-242488.txt ( ) — 166KB
- sprb-20251015.xsd (EX-101.SCH) — 32KB
- sprb-20251015_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Spruce Biosciences, Inc. Date: October 17, 2025 By: /s/ Samir Gharib Samir Gharib President and Chief Financial Officer